315 related articles for article (PubMed ID: 35741760)
21. Genetic Spectrum of Familial Hypercholesterolaemia in the Malaysian Community: Identification of Pathogenic Gene Variants Using Targeted Next-Generation Sequencing.
Razman AZ; Chua YA; Mohd Kasim NA; Al-Khateeb A; Sheikh Abdul Kadir SH; Jusoh SA; Nawawi H;
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499307
[TBL] [Abstract][Full Text] [Related]
22. ABCG5 and ABCG8 genetic variants in familial hypercholesterolemia.
Reeskamp LF; Volta A; Zuurbier L; Defesche JC; Hovingh GK; Grefhorst A
J Clin Lipidol; 2020; 14(2):207-217.e7. PubMed ID: 32088153
[TBL] [Abstract][Full Text] [Related]
23. Compound heterozygous LDLR variant in severely affected familial hypercholesterolemia patient.
Al-Allaf FA; Alashwal A; Abduljaleel Z; Taher MM; Bouazzaoui A; Abalkhail H; Al-Allaf AF; Athar M
Acta Biochim Pol; 2017; 64(1):75-79. PubMed ID: 27878139
[TBL] [Abstract][Full Text] [Related]
24. Novel combined variants of LDLR and LDLRAP1 genes causing severe familial hypercholesterolemia.
Alnouri F; Athar M; Al-Allaf FA; Abduljaleel Z; Taher MM; Bouazzaoui A; Al Ammari D; Karrar H; Albabtain M
Atherosclerosis; 2018 Oct; 277():425-433. PubMed ID: 30270081
[TBL] [Abstract][Full Text] [Related]
25. A novel low-density lipoprotein receptor variant in a Ukrainian patient: a case report and overview of the disease-causing low-density lipoprotein receptor variants associated to familial hypercholesterolemia.
Moffa S; Onori ME; De Paolis E; Ricciardi Tenore C; Perrucci A; Pontecorvi A; Giaccari A; Urbani A; Minucci A
Mol Biol Rep; 2022 Feb; 49(2):1623-1630. PubMed ID: 34846648
[TBL] [Abstract][Full Text] [Related]
26. Lipid phenotype and heritage pattern in families with genetic hypercholesterolemia not related to LDLR, APOB, PCSK9, or APOE.
Jarauta E; Pérez-Ruiz MR; Pérez-Calahorra S; Mateo-Gallego R; Cenarro A; Cofán M; Ros E; Civeira F; Tejedor MT
J Clin Lipidol; 2016; 10(6):1397-1405.e2. PubMed ID: 27919357
[TBL] [Abstract][Full Text] [Related]
27. Phenotypic variability in 4 homozygous familial hypercholesterolemia siblings compound heterozygous for LDLR mutations.
Rabacchi C; Bigazzi F; Puntoni M; Sbrana F; Sampietro T; Tarugi P; Bertolini S; Calandra S
J Clin Lipidol; 2016; 10(4):944-952.e1. PubMed ID: 27578127
[TBL] [Abstract][Full Text] [Related]
28. Genetic Analysis of Japanese Children Clinically Diagnosed with Familial Hypercholesterolemia.
Nagahara K; Nishibukuro T; Ogiwara Y; Ikegawa K; Tada H; Yamagishi M; Kawashiri MA; Ochi A; Toyoda J; Nakano Y; Adachi M; Mizuno K; Hasegawa Y; Dobashi K
J Atheroscler Thromb; 2022 May; 29(5):667-677. PubMed ID: 34011801
[TBL] [Abstract][Full Text] [Related]
29. Impact of LDLR and PCSK9 pathogenic variants in Japanese heterozygous familial hypercholesterolemia patients.
Hori M; Ohta N; Takahashi A; Masuda H; Isoda R; Yamamoto S; Son C; Ogura M; Hosoda K; Miyamoto Y; Harada-Shiba M
Atherosclerosis; 2019 Oct; 289():101-108. PubMed ID: 31491741
[TBL] [Abstract][Full Text] [Related]
30. The
Meshkov A; Ershova A; Kiseleva A; Zotova E; Sotnikova E; Petukhova A; Zharikova A; Malyshev P; Rozhkova T; Blokhina A; Limonova A; Ramensky V; Divashuk M; Khasanova Z; Bukaeva A; Kurilova O; Skirko O; Pokrovskaya M; Mikova V; Snigir E; Akinshina A; Mitrofanov S; Kashtanova D; Makarov V; Kukharchuk V; Boytsov S; Yudin S; Drapkina O
Genes (Basel); 2021 Jan; 12(1):. PubMed ID: 33418990
[TBL] [Abstract][Full Text] [Related]
31. The benign c.344G > A: p.(Arg115His) variant in the LDLR gene interpreted from a pedigree-based genetic analysis of familial hypercholesterolemia.
Hori M; Takahashi A; Son C; Ogura M; Harada-Shiba M
Lipids Health Dis; 2020 Apr; 19(1):62. PubMed ID: 32252761
[TBL] [Abstract][Full Text] [Related]
32. Screening of PCSK9 and LDLR genetic variants in Familial Hypercholesterolemia (FH) patients in India.
Reddy LL; Shah SAV; Ponde CK; Dalal JJ; Jatale RG; Dalal RJ; Rajani RM; Pillai SK; Vanjani CV; Ashavaid TF
J Hum Genet; 2021 Oct; 66(10):983-993. PubMed ID: 33864011
[TBL] [Abstract][Full Text] [Related]
33. Refinement of pathogenicity classification of variants associated with familial hypercholesterolemia: Implications for clinical diagnosis.
Di Costanzo A; Minicocci I; D'Erasmo L; Commodari D; Covino S; Bini S; Ghadiri A; Ceci F; Maranghi M; Catapano AL; Gazzotti M; Casula M; Montali A; Arca M
J Clin Lipidol; 2021; 15(6):822-831. PubMed ID: 34756585
[TBL] [Abstract][Full Text] [Related]
34. Identification of pathogenic variants in the Brazilian cohort with Familial hypercholesterolemia using exon-targeted gene sequencing.
Borges JB; Oliveira VF; Dagli-Hernandez C; Ferreira GM; Barbosa TKAA; da Silva Rodrigues Marçal E; Los B; Malaquias VB; Bortolin RH; Freitas RCC; Mori AA; Bastos GM; Gonçalves RM; Araújo DB; Zatz H; Bertolami A; Faludi AA; Bertolami MC; de Moraes Rego Souza AG; França JÍD; Thurow HS; Hirata TDC; Nakaya HTI; Jannes CE; da Costa Pereira A; Silbiger VN; Luchessi AD; Araújo JNG; Nakazone MA; Carmo TS; Souza DRS; Moriel P; Wang JYT; Naslavsky MS; Gorjão R; Pithon-Curi TC; Curi R; Fajardo CM; Wang HL; Garófalo AR; Cerda A; Sampaio MF; Hirata RDC; Hirata MH
Gene; 2023 Jul; 875():147501. PubMed ID: 37217153
[TBL] [Abstract][Full Text] [Related]
35. Establishing the Mutational Spectrum of Hungarian Patients with Familial Hypercholesterolemia.
Madar L; Juhász L; Szűcs Z; Kerkovits L; Harangi M; Balogh I
Genes (Basel); 2022 Jan; 13(1):. PubMed ID: 35052492
[TBL] [Abstract][Full Text] [Related]
36. In silico analysis of upstream variants in Brazilian patients with Familial hypercholesterolemia.
de Araújo JNG; de Oliveira VF; Borges JB; Dagli-Hernandez C; Marçal EDSR; Freitas RCC; Bastos GM; Gonçalves RM; Faludi AA; Jannes CE; Pereira ADC; Hirata RDC; Hirata MH; Luchessi AD; Silbiger VN
Gene; 2023 Jan; 849():146908. PubMed ID: 36167182
[TBL] [Abstract][Full Text] [Related]
37. The LDLR c.501C>A is a disease-causing variant in familial hypercholesterolemia.
Hu H; Chen R; Hu Y; Wang J; Lin S; Chen X
Lipids Health Dis; 2021 Sep; 20(1):101. PubMed ID: 34511120
[TBL] [Abstract][Full Text] [Related]
38. Unraveling the genetic background of individuals with a clinical familial hypercholesterolemia phenotype.
Medeiros AM; Alves AC; Miranda B; Chora JR; Bourbon M;
J Lipid Res; 2024 Feb; 65(2):100490. PubMed ID: 38122934
[TBL] [Abstract][Full Text] [Related]
39. The Genetic Spectrum of Familial Hypercholesterolemia (FH) in the Iranian Population.
Fairoozy RH; Futema M; Vakili R; Abbaszadegan MR; Hosseini S; Aminzadeh M; Zaeri H; Mobini M; Humphries SE; Sahebkar A
Sci Rep; 2017 Dec; 7(1):17087. PubMed ID: 29213121
[TBL] [Abstract][Full Text] [Related]
40. The genetic spectrum of familial hypercholesterolemia in the central south region of China.
Xiang R; Fan LL; Lin MJ; Li JJ; Shi XY; Jin JY; Liu YX; Chen YQ; Xia K; Zhao SP
Atherosclerosis; 2017 Mar; 258():84-88. PubMed ID: 28235710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
